Pa. Stuck In Litigation Limbo As Purdue Inks 1st Opioid Deal
As litigation over damages from the opioid epidemic moves ahead across the nation, including Purdue Pharma's recent $270 million deal to end claims in Oklahoma, attorneys in Pennsylvania are expressing frustration...To view the full article, register now.
Already a subscriber? Click here to view full article